Interesting News
- Social Media as a Tool in Medicine
May 7, 2013 | 9:06 amInteresting article/review in Circulation (American Heart Association) about Digital Social Networks and Health. Free full text. [More...]
- Family history of Alzheimer’s doubles risk
May 1, 2013 | 9:36 amRelatives of people with Alzheimer’s disease are more than twice as likely to develop abnormal brain pathology associated with the condition compared with individuals who don’t have a family history of the disease, a recent study in PLOS ONE said. [More...]
- Bipolar Disorder – A Focus on Depression
March 20, 2013 | 7:52 amLive today, neuroscienceCME Live and On Demand Bipolar Disorder – A Focus on Depression. [More...]
-
Archive for Interesting News »
- Social Media as a Tool in Medicine
Latest Reader Poll
Subscribe to this blog via E-mail
-
Recent Posts
Recent Comments
Archives
- June 2013
- May 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
Categories
- Addiction
- ADHD
- Adherence
- Adolescents
- Adult immunization
- Advertising
- Alzheimer's Disease
- Antipsychotic medication
- Anxiety Disorders
- Award
- Biomarker
- Bipolar Depression
- Bipolar Disorder
- Brain Scan
- Cardiovascular Risk Factors
- Child & Adolescent
- Chronic Pain
- Clinical trial
- Clinical trials
- CME
- CMS
- Cognition
- Cognitive Behavior Therapy
- Cognitive Stimulation
- Communicatin
- CPT Codes
- Creativity
- Deep Brain Stimulation
- Dementia
- Depression
- Diabetes
- Diabetic peripheral neuropathy
- Diagnosis
- Digital medicine
- Disability
- Discrimination
- Domestic violence
- Drug Development
- Drugs
- DSM-5
- Early intervention
- Education
- EEG
- Electronic Medical Record
- Epidemiology
- Epilepsy
- Excessive sleepiness
- Food
- Games
- Gender
- Gene therapy
- Genetics
- Guideline
- Happiness
- Headache
- Health Industry
- Heart health
- History
- Imaging
- Influenza
- Internet
- Internet Addiction
- Job satisfaction
- Love
- Lung Cancer
- Maintenance of Certification
- MCI
- Measurement-based care
- Medical Education
- Medical health
- Memory
- Mental health
- Metabolic screening
- Migraine
- monoclonal antibodies
- Mood
- MRI
- Multiple sclerosis
- Nature
- Negative symptoms
- Neuroscience
- News
- NIMH
- Obesity
- Oncology
- Opioids
- Pain
- Parkinson's Disease
- Patient-centered interview
- PET
- Phobia
- Physical exercise
- Physician salaries
- Physician Sunshine Act
- Physician workloads
- Pneumococcal disease
- Post-partum
- Practice guideline
- Primary Care
- Professionalism
- Psychological interventions
- Psychosis
- PTSD
- Quality health
- Radiology
- Relapse
- Remission
- Research
- Rheumatoid arthritis
- Risk
- Schizophrenia
- Science
- Shift work
- Sleep
- Sleep Apnea
- Smartphones
- Smoking cessation
- Social media
- Social Networking
- Social networks
- Special News
- Sports Psychiatry
- Stigma
- Stroke
- Substance abuse
- Technology
- Therapeutic relationship
- Transcranial magnetic stimulation
- Treatment
- Treatment resistant depression
- Uncategorized
- Undertreatment
- Vaccination
- Vascular dementia
- Vascular dementia
- Virtual Environments
- Wellness
- Women
Category Archives: Clinical trial
Deep Brain Stimulation for Alzheimer’s Disease
Investigators from Brown University and two Rhode Island hospitals are participating a clinical trial investigating the use of deep brain stimulation (DBS) as a treatment for patients with Alzheimer’s disease. DBS is currently FDA approved to treat Parkinson’s disease, Tourette’s … Continue reading
Posted in Alzheimer's Disease, Clinical trial, Cognition, Deep Brain Stimulation, Dementia, Uncategorized
Comments Off
Reasons Alzheimer’s Patients are Omitted from Clinical Trials
A study in the British Journal of Clinical Pharmacology assessed the reasons that prevent Alzheimer’s disease (AD) patients from being included in clinical trials. It is interesting that no study has evaluated the main medical and non-medical factors that explain … Continue reading
Posted in Alzheimer's Disease, Clinical trial, Clinical trials, Dementia
Comments Off
First “Virtual” Clinical Trial Allowing Patients to Participate Regardless Of Geography
Pfizer Inc. announced that it is conducting the first-ever randomized clinical trial under an investigational new drug (IND) application that manages study participation entirely using electronic tools and allows patients to participate in the clinical trial regardless of their proximity … Continue reading
Posted in Clinical trial, News, Technology
Comments Off